NG2 ligand peptide

NG2 Ligand Peptide is a short targeting peptide identified through phage-displayed peptide library screening. It specifically binds NG2, also known as CSPG4, a transmembrane proteoglycan homologous to melanoma-associated antigens and frequently overexpressed in multiple tumor types. NG2 is involved in tumor growth, angiogenesis, migration, and cancer progression. This peptide has demonstrated binding specificity in both in vitro and in vivo models. NG2 Ligand Peptide is widely used in tumor-targeting research, targeted drug delivery, cancer imaging, nanoparticle design, and studies of NG2-associated tumor biology and therapeutic targeting.

Product Name: NG2 ligand peptide

Sequence One Letter Code: TAASGVRSMH

Sequence Three Letter Code: H-Thr-Ala-Ala-Ser-Gly-Val-Arg-Ser-Met-His-OH

Chemical Formula:C40H69N15O14S

Molecular Weight: 1016.2

Purity: ≥ 95%

Form: Lyophilized

Storage Conditions: - 20 °C

Source / Species: Phage displayed library

Conjugation: Unconjugated